Table 6.
Associations between Alzheimer’s disease (AD) and late-onset epilepsy (LOE), all of Us patient population (N = 52,493)a.
| AD ~ LOE | LOE ~ AD | |||||
|---|---|---|---|---|---|---|
| N | HR [95% CI] | P-value | N | HR [95% CI] | P-value | |
| Basic modela | ||||||
| Cox proportional hazard | 52,319 | 3.95 (2.77, 5.63) | < 0.001* | 52,206 | 2.96 (1.89, 4.61) | < 0.001* |
| Fine and Gray | 52,319 | 2.47 (1.69, 3.60) | < 0.001* | 52,206 | 1.98 (1.22, 3.20) | 0.005* |
| Adjusted for AD geneticsb | ||||||
| Cox proportional hazard | 52,319 | 3.96 (2.78, 5.64) | < 0.001* | 52,206 | 2.96 (1.89, 4.62) | < 0.001* |
| Fine and Gray | 52,319 | 2.49 (1.71, 3.63) | < 0.001* | 52,206 | 1.98 (1.22, 3.21) | 0.001* |
CI confidence interval, EHR electronic health record.
[a]Basic model adjustments include age at first visit, sex, EHR record length, hypertension, diabetes, stroke, and hyperlipidemia status.
[b] Additionally adjusted for APOE-ε4 count and AD polygenic risk score (without APOE region) in [b].